Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Ludolph

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Current Opinion in Neurology|September 8, 2025
Progress in ALS research 2025Albert Ludolph
Therapeutic Advances in Neurological Disorders|September 2, 2017
Edaravone: a baby in the bathwater?Albert Ludolph
The Lancet. Neurology|October 11, 2014
Amyotrophic lateral sclerosis: new ideas from cancerGiancarlo Logroscino, Albert Ludolph
Therapeutic Advances in Neurological Disorders|January 23, 2025
Tofersen and other antisense oligonucleotides in ALSAlbert Ludolph, Maximilian Wiesenfarth
Archives Italiennes De Biologie|February 7, 2018
The emerging picture of ALS: a multisystem, not only a "motor neuron diseaseVincenzo Silani, Albert Ludolph, Francesco Fornai
The Cochrane Database of Systematic Reviews|June 7, 2013
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseJohannes Brettschneider, Jerome Kurent, Albert Ludolph
The Cochrane Database of Systematic Reviews|July 23, 2008
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseJohannes Brettschneider, Jerome Kurent, Albert Ludolph, et al.
Archives Italiennes De Biologie|February 7, 2018
The multisystem degeneration amyotrophic lateral sclerosis - neuropathological staging and clinical translationFederico Verde, Kelly Del Tredici, Heiko Braak, et al.
Deutsches Arzteblatt International|July 24, 2009
Depression and quality of life in patients with amyotrophic lateral sclerosisDorothée Lulé, Sonja Häcker, Albert Ludolph, et al.
Expert Review of Proteomics|August 12, 2017
Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosisPeggy Barschke, Patrick Oeckl, Petra Steinacker, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Current Opinion in Neurology|September 8, 2025
Progress in ALS research 2025Albert Ludolph
Therapeutic Advances in Neurological Disorders|September 2, 2017
Edaravone: a baby in the bathwater?Albert Ludolph
The Lancet. Neurology|October 11, 2014
Amyotrophic lateral sclerosis: new ideas from cancerGiancarlo Logroscino, Albert Ludolph
Therapeutic Advances in Neurological Disorders|January 23, 2025
Tofersen and other antisense oligonucleotides in ALSAlbert Ludolph, Maximilian Wiesenfarth
Archives Italiennes De Biologie|February 7, 2018
The emerging picture of ALS: a multisystem, not only a "motor neuron diseaseVincenzo Silani, Albert Ludolph, Francesco Fornai
The Cochrane Database of Systematic Reviews|June 7, 2013
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseJohannes Brettschneider, Jerome Kurent, Albert Ludolph
The Cochrane Database of Systematic Reviews|July 23, 2008
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron diseaseJohannes Brettschneider, Jerome Kurent, Albert Ludolph, et al.
Archives Italiennes De Biologie|February 7, 2018
The multisystem degeneration amyotrophic lateral sclerosis - neuropathological staging and clinical translationFederico Verde, Kelly Del Tredici, Heiko Braak, et al.
Deutsches Arzteblatt International|July 24, 2009
Depression and quality of life in patients with amyotrophic lateral sclerosisDorothée Lulé, Sonja Häcker, Albert Ludolph, et al.
Expert Review of Proteomics|August 12, 2017
Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosisPeggy Barschke, Patrick Oeckl, Petra Steinacker, et al.
Pageof 12